Invivyd, Inc.
Biopharmaceutical company developing antibody-based solutions for viral diseases.
IVVD | US
Overview
Corporate Details
- ISIN(s):
- US00534A1025
- LEI:
- Country:
- United States of America
- Address:
- 209 CHURCH STREET, 6510 NEW HAVEN
- Website:
- https://invivyd.com/
- Sector:
- Manufacturing
Description
Invivyd, Inc. is a biopharmaceutical company focused on the discovery, development, and commercialization of antibody-based solutions for serious viral infectious diseases. The company's mission is to rapidly and continually deliver therapies that keep pace with evolving viral threats. Utilizing a proprietary technology platform, Invivyd develops monoclonal antibody candidates designed to be more potent and resistant to virus evolution than the human immune system. Its pipeline is initially focused on addressing SARS-CoV-2, with plans to expand into other high-need indications such as influenza.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Invivyd, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Invivyd, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Invivyd, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
